Clinical Study | Open Access
Close to Transplant Renal Artery Stenosis and Percutaneous Transluminal Treatment
Purpose. To evaluate the efficacy of percutaneous transluminal angioplasty (PTA) in the management of arterial stenosis located close to the allograft anastomosis (close-TRAS). Materials and Methods. 31 patients with renal transplants were admitted to our institution because of persistent hypertension and impairment of transplant renal function and underwent angiography for vascular investigation. 27 were diagnosed suffering from transplant renal artery stenosis (TRAS), whereas 4 had severe iliac artery stenosis proximal to the transplant anastomosis (Prox-TRAS). 3 cases of TRAS coexisted with segmental renal arterial stenosis, whereas 3 other cases of TRAS were caused by kinking and focal stenosis in the middle of the transplanted renal artery. Results. Angioplasty and stenting were successfully applied to all patients with iliac artery stenosis as well as to those with TRAS and segmental artery stenosis. Two of three patients with kinking were well treated with angioplasty and stenting, whereas one treated only with angioplasty necessitated surgery. No major procedure-related complications appeared, and the result was decrease of the serum creatinine level and of the blood pressure. Conclusions. PTA is the appropriate initial treatment of TRAS and close-TRAS, with low morbidity and mortality rates, achieving improvement of graft function and amelioration of hypertension.
Hypertension is a recognized complication following renal transplantation, occurring in approximately 60% of the recipients, and it is a major risk factor for accelerated cardiovascular disease and mortality after transplantation [1, 2]. The etiology of posttransplant hypertension is multifactorial including many conditions such as acute and chronic rejection, immunosuppressant therapy, graft dysfunction, and renal artery stenosis .
TRAS is a well known cause of posttransplant hypertension, and its incidence varies from 1% to 23% depending on the study and the transplantation center, reflecting the heterogeneous criteria used to establish the diagnosis and the presence of asymptomatic lesions [4–6]. Arterial complications lead to graft dysfunction and loss in approximately 5% of all renal transplant recipients [7, 8].
The most common arterial complication following kidney transplantation is TRAS, presented with resistant hypertension and serum creatinine elevation.
Our special issue on this abstract, concerning patients with TRAS, is the so-called close-TRAS, id stenosis of proximal iliac or segmental renal arteries and the transplant renal artery stenosis plus kinking.
Herein we report 3 patients among 31 with clinical manifestations of TRAS who were diagnosed with TRAS and segmental arterial stenosis of graft as well; after undergoing angiography, both of TRAS and segmental arterial stenosis were managed with PTA without any failure.
Although Prox-TRAS is rare, it should be considered in patients with renal dysfunction and resistant hypertension since it has similar clinical symptoms to those of TRAS [9, 10]. Therefore, angiographic examination of patients with hypertension after transplantation should include evaluation of the transplanted renal artery as well as of the aortoiliac axes. This paper presents also four patients who developed arterial hypertension because of proximal iliac artery stenosis.
According to the literature, many factors can provoke TRAS such as chronic rejection, kinking, or compression of a long renal artery and atherosclerotic disease . In this paper, we present also 3 cases of TRAS caused by kinking and focal stenosis in the middle of renal transplanted artery.
2. Materials and Method
In a series of 627 renal transplants, performed in our service between January 1999 until June 2010 in a total of 27 patients (15 men and 12 women, aged between 26 to 66 years old (mean 47 years)), 12/27 from cadaveric and 15/27 from living donors presented with refractory hypertension and increased creatinine blood level. In particular, in all 27 patients, systolic and diastolic blood pressure and the number of antihypertensive drugs at the time of diagnosis of the stenosis had significantly increased compared to the time period before or early after renal transplantation (RTX). All patients showed impairment of renal function (as documented by eGFR). With regard to vascular risk factors hypertension was present in 27/27 patients, diabetes mellitus in 12/27, hyperlipidemia in 17/27, smoking in 8/27, hyperuricemia in 22/27, and dialysis duration ranged between 1 to 12 years. Seven patients had preexisting renovascular disease. The time between transplantation and deterioration of renal function or hypertension ranged between 2 days and 89 months (mean: 14 months). In 14 of 27 patients this time was less than 6 months (mean: 3.7 months). Color Doppler Ultrasound (CDU) proceeded the angiographic investigation, based on the following diagnostic protocol. After measurement of peak-systolic () and end-diastolic () velocities within interlobar arteries of the upper pole, midportion, and lower pole of the kidney, was calculated from the area under the curve of one pulse cycle. The Doppler waveform was analyzed, and the Persistence Index (PI) was calculated according to the formula
At least three PIs were averaged over time to give a mean value. Further, peak-systolic velocities within the graft arteries were measured under continuous correction of the Doppler beam angle.
TRAS was suspected in case of an increase of % within the stenosis as compared to the pre- or poststenotic flow velocity. Further, intrarenal pulsus parvus et tardus was used as an indirect sign for stenosis. Prox-TRAS was assumed in case of a high systolic peak velocity ( cm/s) within the aortoiliac region and if the triphasic form of the flow curve was lost distal to the anastomosis with the transplant artery. Pulsus parvus et tardus and/or small PI values () without presence of TRAS were also indirect signs for Prox-TRAS.
These three patients presented with persistent hypertension ( and mmHg), renal dysfunction (eGFR calculated with Cockroft-Gault formula ml/min), and low PI (). Diagnostic angiography followed which revealed significant stenosis of partial branch of renal artery apart from the stenosis of the main renal artery. Segmental lesion was dilated by use of a thin, cardiologic balloon of 2.5 mm of diameter, whereas TRAS was managed with stent implantation apart from angioplasty (Figures 1(b) and 2(b)).
We also refer to 4 patients who developed persistent arterial hypertension ( and mmHg) despite the increase of prescribed antihypertensive medication and impairment of renal function (eGFR ml/min) raising high suspicion of TRAS. CDU investigation illustrated the presence of pulsus parvus et tardus in transplant renal and intrarenal arteries, and PIs were slightly below the normal range (). The interval between transplantation and graft dysfunction ranged from 2 months up to 4 years.
Angiography revealed severe ipsilateral iliac artery stenosis (>70%), proximal to the anastomotic site (Figures 3(a) and 4(a)). The cause of Prox-TRAS was atherosclerosis reflecting the disease of the recipients, as these were characterized by coronary artery occlusive disease, older age, and longer time on dialysis before RTX. Successful angioplasty and stenting were performed in all four patients by insertion of an 8 mm diameter, 40 mm length balloon expandable stent, immediately after the angiography in most of the cases (Figures 3(b) and 4(b)).
A subgroup of 3 recipients was identified, in which TRAS resulted from kinking of the renal artery and from segmental stenosis in its medial part (Figures 5(a) and 6(a)). The documented manifestations were hypertension ( and mmHg), despite the increase in antihypertensive medication from 2 to 3, deterioration of renal function (eGFR ml/min), and low PI values () in CDU investigation. The first attempt was to resolve the obstructed lesion in all three patients by means of angioplasty (Figures 5(b) and 6(b)), without any positive outcome in imaging evaluation (Figure 6(c)), therefore, the insertion of a stent followed, which was successfully performed in 2 patients (Figure 5(c)), while the remained one underwent open surgery.
Resolution of both stenotic sites was achieved in all three patients with TRAS and segmental renal artery stenosis, and no major related-to-the procedure complication took place.
This method was technically feasible in all 4 patients with Prox-TRAS (100%), without any procedure-related complication.
PTA with stenting was successfully performed in 2 of 3 cases with kinking (66%)—or otherwise 30/31 id 96.7%. Open surgery was performed to one patient without any major complication related to the procedure, and there was immediate response to treatment in all 3 cases.
During the first 7 postoperative days nearly all patients showed normalization of renal function and decline of arterial blood pressure. In particular, in the subgroup of patients with Prox-TRAS diastolic and systolic blood pressure was reduced to mmHg one week after intervention and mmHg at the end of observation, number of antihypertensive drugs was declined to 2 and 1 at the mentioned time points, and eGFR was ml/min post-PTA and at the end of observation. Besides in the subgroup of patients with TRAS and segmental artery stenosis the recorded parameters were blood pressure mmHg, eGFR ml/min one year after PTA and mmHg, eGFR at the end of observation. There was also reduction in the number of antihypertensive medication from 3 to 1. Last at the previously mentioned time points, in the subgroup of patients with TRAS and kinking, we documented systolic and diastolic pressure of mmHg and mmHg, decreased number of antihypertensive drugs from 3 to 2 and to eGFR min/mL and min/mL, respectively.
Apart from what is mentioned above, the main group of patients with anastomotic TRAS had a successful angioplasty and stenting with a clear amelioration of renal function and hypertension parameters.
In addition, after TRAS was corrected, the ultrasonographic procedure was repeated at 3, 6, and 12 months and yearly thereafter. We determined the peak systolic velocity (), the end-diastolic velocity (), and mean velocity () in order to calculate PI, using the same formula mentioned before. The PI values were the average of three measurements in segmental arteries from the upper, middle, and lower third of the kidney. PI increased significantly from to after dilatation of stenosis while with respect to Prox-TRAS the flow profile within the distal segment of the iliac artery became triphasic, whereas it was still monophasic or revealed positive end-diastolic flow proximal to the anastomosis. At the end of observation time PI had slightly decreased from to .
During the follow-up period no recurrence had been recorded. Two of the 27 patients died from irrelevant causes (one from heart attack and one from sepsis) with a normally functioning renal transplant. The remaining 25 patients have stable renal function, thus our patency rate, including the operated graft, reached 100%.
As evidenced by review of the literature, there is lack of reports concerning segmental artery stenosis of the transplanted kidney, alone and it is challenging to identify its participation in graft’s dysfunction. In our opinion, if segmental artery stenosis happened alone, early, significant clinical manifestations would not be present, and therefore, no treatment option would have been employed, since it was a random finding while investigating TRAS of the transplanted kidney with angiographic means.
Although this study is limited by its small group of patients, it is suggestive that PTA with or without stenting can be as effective and safe dealing with two stenotic sites as dealing with TRAS alone.
TRAS can be provoked by multiple reasons, depending on its location and the mean time lapse between transplantation and its onset. In particular, stenosis occurring later after transplantation usually reveals atherosclerotic disease either of the renal transplant artery or of the proximal iliac artery . Prox-TRAS is rare, but its clinical manifestations mimic those of TRAS when it appears late after transplantation in patients with stenosis presenting immediately after transplantation, whereas in patients who already have established stable renal function, apart from renovascular hypertension and ischemic nephropathy, there are also signs of peripheral arterial obstruction disease of the lower extremity since peripheral artery resistance has already been developed [7, 9]. As discussed by Humar et al. , physical examination of a renal recipient who suffered from resistant hypertension and graft dysfunction revealed a diminished femoral pulse and a significantly lower ankle-brachial index on the right (versus left) lower extremity, that suggested a stenosis of right iliac artery which was afterwards confirmed by angiographic investigation.
As older persons are accepted as transplantation candidates, and as recipient population ages, the presence of occlusive atherosclerosis of the native aortoiliac system or its development proximal to the graft should be expected . Therefore follow-up examination should take into account vascular problems that are related to renal transplantation, as early diagnosis of them leads to sufficient management of graft’s impairment. Colour Doppler Ultrasonography and Magnetic Resonance Angiography (MRA) may arouse suspicion of disease even in less symptomatic cases; however definite diagnosis of significant arterial stenosis is accomplished by arteriography combined with angioplasty and stenting when indicated [11, 16]. Moreover in our center the established practice is to look into clinical manifestations of allograft’s malfunction and severe hypertension by angiography procedure regardless of the findings of tomographic means .
In this paper, the treatment of iliac artery stenosis proximal to renal anastomosis was successful 100% and remained patent during at least 3 years of followup in all four patients. As discussed in other studies, technical success rate of PTA in treatment of Prox-TRAS is recorded to reach 95% while its 3- to 5-year patency rates range from 75% to 90% . In comparison to open surgery, PTA has been documented to carry lower morbidity and mortality rate and has been established as first-line treatment of significant arterial stenosis of transplant recipients when it is viable .
After thorough examination of the literature we have assumed that aetiology of distal stenosis is not clearly specified, yet mechanical or immunological damage seems to be related, whereas proximal stenosis is a consequence of recipient’s atherosclerotic arterial disease and anastomotic stenosis is resulted from technical reasons such as “faulty surgical technique” or postoperative fibrosis . In addition, kinking of the artery can occur when the artery is longer than the vein, and this may provoke or stimulate the hemodynamic and functional changes of TRAS [9, 19].
With regard to the outcomes of this paper, graft nephrectomy was avoided with the selected therapeutic approaches, and finally graft function recovery was achieved on the regular followup, indicating that PTA with stenting can accomplish similar efficacy with open surgery, when viable.
In summary, stenotic lesions not only in the transplanted renal artery but also more proximally or distally (close to) must be considered as source of hypertension and graft’s dysfunction and should be investigated and treated with PTA when it is needed, because of the positive risk-benefit estimate of this procedure, taking into account its low invasiveness and absence of severe complications.
The importance of immediate diagnosis and fast intervention, once the diagnosis of TRAS is established, is of major significance, while we are convinced that case-specific selection of therapeutic procedures are required for TRAS treatment.
These cases illustrate that PTA is a reliable therapeutic approach and its high rate of clinical success even in more complicated cases establishes it as the first-line treatment in management of TRAS. Familiarity with this procedure facilitates prompt vascular diagnosis and treatment.
- A. Voiculescu, M. Schmitz, M. Hollenbeck et al., “Management of arterial stenosis affecting kidney graft perfusion: a single-centre study in 53 patients,” American Journal of Transplantation, vol. 5, no. 7, pp. 1731–1738, 2005.
- A. O. Ojo, J. A. Hanson, R. A. Wolfe, A. B. Leichtman, L. Y. Agodoa, and F. K. Port, “Long-term survival in renal transplant recipients with graft function,” Kidney International, vol. 57, no. 1, pp. 307–313, 2000.
- A. Kaul, R. K. Sharma, A. Gupta, and U. Singh, “Spectrum of hypertension in post transplant,” Journal of Association of Physicians of India, vol. 58, no. 4, pp. 221–224, 2010.
- B. F. Henning, S. Kuchlbauer, C. A. Boger et al., “Percutaneous transluminal angioplasty as first-line treatment of transplant renal artery stenosis,” Clinical Nephrology, vol. 71, pp. 543–549, 2009.
- S. Bruno, G. Remuzzi, and P. Ruggenenti, “Transplant renal artery stenosis,” Journal of the American Society of Nephrology, vol. 15, no. 1, pp. 134–141, 2004.
- M. Lacombe, “Arterial stenosis complicating renal allotransplantation in man: a study of 38 cases,” Annals of Surgery, vol. 181, no. 3, pp. 283–288, 1975.
- J. Safa, N. Nezami, M. K. Tarzamni, S. Zarforooshan, B. Rahimi-Ardabili, and A. Bohlouli, “Post-transplant urological and vascular complications,” Saudi Journal of Kidney Diseases and Transplantation, vol. 20, pp. 867–871, 2009.
- M. Jordan, G. T. Cook, and C. J. Cardella, “Ten years of experience with vascular complications in renal transplantation,” Journal of Urology, vol. 128, no. 4, pp. 689–692, 1982.
- P. Pappas, G. Zavos, S. Kaza et al., “Angioplasty and stenting of arterial stenosis affecting renal transplant function,” Transplantation Proceedings, vol. 40, no. 5, pp. 1391–1396, 2008.
- A. Voiculescu, M. Hollenbeck, J. Plum et al., “Iliac artery stenosis proximal to a kidney transplant: clinical findings, duplex-sonographic criteria, treatment and outcome,” Transplantation, vol. 76, no. 2, pp. 332–339, 2003.
- W. Hedegard, W. E. Saad, and M. G. Davies, “Management of vascular and nonvascular complications after renal transplantation,” Techniques in Vascular and Interventional Radiology, vol. 12, no. 4, pp. 240–262, 2009.
- J. R. Beecroft, D. K. Rajan, T. W. Clark, M. Robinette, and S. W. Stavropoulos, “Transplant renal artery stenosis: outcome after percutaneous intervention,” Journal of Vascular and Interventional Radiology, vol. 15, no. 12, pp. 1407–1413, 2004.
- D. Ridgway, S. A. White, M. Nixon, S. Carr, K. Blanchard, and M. L. Nicholson, “Primary endoluminal stenting of transplant renal artery stenosis from cadaver and non-heart-beating donor kidneys,” Clinical Transplantation, vol. 20, no. 3, pp. 394–400, 2006.
- A. Humar, B. Grubbs, D. Zapzalka, W. Nazarian, D. Hunter, and A. Matas, “Isolated iliac artery stenosis as causes of kidney graft dysfunction post-transplant,” Clinical Transplantation, vol. 12, no. 5, pp. 406–408, 1998.
- A. Moss, J. S. Najarian, D. E. Sutherland et al., “5,000 kidney transplants—a single-center experience,” Clinical Transplants, pp. 159–171, 2000.
- H. Gufler, W. Weimer, K. Neu, S. Wagner, and W. S. Rau, “Contrast enhanced MR angiography with parallel imaging in the early period after renal transplantation,” Journal of Magnetic Resonance Imaging, vol. 29, no. 4, pp. 909–916, 2009.
- R. Dourado, P. D. A. Gonçalves, M. Almeida et al., “Peripheral artery disease: a cause of refractory hypertension after renal transplantation,” Revista Portuguesa de Cardiologia, vol. 27, no. 3, pp. 353–357, 2008.
- S. Sharma, A. Potdar, and A. Kulkarni, “Percutaneous transluminal renal stenting for transplant renal artery stenosis,” Catheterization and Cardiovascular Interventions, vol. 77, pp. 287–293, 2011.
- J. H. Peregrin, J. Stríbrná, J. Lácha, and J. Skibová, “Long-term follow-up of renal transplant patients with renal artery stenosis treated by percutaneous angioplasty,” European Journal of Radiology, vol. 66, pp. 512–518, 2008.
Copyright © 2011 Leonardou Polytimi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.